Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.34 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21622528 | 0.99 | KDM4E (0.38) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL12093281 | 0.99 | KDM4E (0.38) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL22257959 | 0.98 | KDM4E (0.38) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL22701838 | 0.97 | KDM4E (0.37) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL18562286 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL22023764 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL22257696 | 0.96 | LIMK1 (0.36) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL22257912 | 0.96 | ALOX5 (0.38) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL22257598 | 0.95 | ALOX5 (0.40) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL20922058 | 0.94 | ALOX5 (0.38) | KDM4EATML3MBTL1ALOX5PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150987-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230150987-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20200231578-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150987-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | SLCO2B1, SLCO2A1, SLCO1B3 | KDM4E 3745/4885ATM 4632/4885L3MBTL1 3258/4885 |
| US-20200231578-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | SLCO2B1, SLCO2A1, SLCO1B3 | KDM4E 3745/4885ATM 4632/4885L3MBTL1 3258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.